{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:12:28Z","timestamp":1774084348265,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":1277,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.bbmt.2011.07.006","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T15:05:40Z","timestamp":1311260740000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Gregory M.","family":"Cote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ephraim P.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alona","family":"Muzikansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred H.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Drappatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy T.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann S.","family":"LaCasce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy S.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.07.006_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","article-title":"Long-term survival in primary CNS lymphoma","volume":"16","author":"Abrey","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1200\/JCO.2003.03.036","article-title":"Treatment of primary\u00a0CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07","volume":"21","author":"Batchelor","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib3","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/01.wnl.0000300671.37279.0e","article-title":"Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation","volume":"70","author":"Gerstner","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2011.07.006_bib5","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1200\/JCO.2003.03.108","article-title":"High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962","volume":"21","author":"Poortmans","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.62.4.544","article-title":"Cognitive status and quality of life after treatment for primary CNS lymphoma","volume":"62","author":"Harder","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2011.07.006_bib7","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2008-10-182253","article-title":"CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)","volume":"113","author":"Boehme","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.07.006_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.07.006_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.bmt.1703917","article-title":"High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma","volume":"31","author":"Cheng","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.07.006_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1083-8791(00)70060-7","article-title":"High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin\u2019s lymphoma","volume":"6","author":"Alvarnas","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.07.006_bib12","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.1996.14.11.3036","article-title":"Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies","volume":"14","author":"van Besien","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib13","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1200\/JCO.1994.12.11.2415","article-title":"Autologous bone marrow transplantation for patients with non-Hodgkin\u2019s lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome\u2014a report by the European Bone Marrow Transplant Lymphoma Registry","volume":"12","author":"Williams","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib14","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2003.05.024","article-title":"Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis","volume":"21","author":"Abrey","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bmt.1705452","article-title":"High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group","volume":"38","author":"Colombat","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.07.006_bib16","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1200\/JCO.2006.06.2117","article-title":"High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma","volume":"24","author":"Illerhaus","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/annonc\/mdn628","article-title":"High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study","volume":"20","author":"Illerhaus","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3324\/haematol.11771","article-title":"High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system","volume":"93","author":"Illerhaus","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.07.006_bib19","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire","volume":"26","author":"Soussain","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","article-title":"Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma","volume":"19","author":"Soussain","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/annonc\/mdl458","volume":"18","author":"Montemurro","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib22","first-page":"1265","article-title":"Plasma pharmacokinetics and tissue distribution of thiotepa in mice","volume":"68","author":"Egorin","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.bbmt.2011.07.006_bib23","first-page":"736","article-title":"Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa","volume":"49","author":"Heideman","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2011.07.006_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF00257448","article-title":"Pharmacokinetics of high-dose busulfan in children","volume":"24","author":"Vassal","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00686397","article-title":"In\u00a0vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient","volume":"30","author":"Hassan","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2011.07.006_bib26","first-page":"113","article-title":"Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy","volume":"4","author":"Hassan","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.07.006_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/1040-8428(92)90092-5","article-title":"Pharmacology of agents used in bone marrow transplant conditioning regimens","volume":"13","author":"Wiebe","year":"1992","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:41:26Z","timestamp":1761057686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1083879111002916"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.07.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}